311 related articles for article (PubMed ID: 34157192)
1. Co-immunization with L-Myc enhances CD8
Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
[TBL] [Abstract][Full Text] [Related]
2. Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8
Chai D; Shan H; Wang G; Zhang Q; Li H; Fang L; Song J; Liu N; Zhang Q; Yao H; Zheng J
Mol Cancer Ther; 2019 Feb; 18(2):323-334. PubMed ID: 30401695
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus vaccine therapy with CD137L promotes CD8
Ding J; Jiang N; Zheng Y; Wang J; Fang L; Li H; Yang J; Hu A; Xiao P; Zhang Q; Chai D; Zheng J; Wang G
Pharmacol Res; 2022 Jan; 175():106034. PubMed ID: 34915126
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity.
Chai D; Qiu D; Shi X; Ding J; Jiang N; Zhang Z; Wang J; Yang J; Xiao P; Wang G; Zheng J
Mol Ther Oncolytics; 2022 Mar; 24():1-13. PubMed ID: 34977338
[TBL] [Abstract][Full Text] [Related]
5. Co-immunizing with PD-L1 induces CD8
Guo S; Xiao P; Li B; Wang W; Wang S; Lv T; Xu X; Chen C; Huang L; Li Z; Tang L; Peng L; Wang H
Int Immunopharmacol; 2020 Jul; 84():106516. PubMed ID: 32334387
[TBL] [Abstract][Full Text] [Related]
6. Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinoma.
Sun H; Li J; Hu W; Yan Y; Guo Z; Zhang Z; Chen Y; Yao X; Teng L; Wang X; Li L; Chai D; Zheng J; Wang G
Mol Immunol; 2021 Nov; 139():184-192. PubMed ID: 34560414
[TBL] [Abstract][Full Text] [Related]
7. Mesenteric CD103
Zhao H; Yang J; Qian Q; Wu M; Li M; Xu W
Front Immunol; 2018; 9():2986. PubMed ID: 30619341
[TBL] [Abstract][Full Text] [Related]
8. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
9. Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses.
Semmrich M; Plantinga M; Svensson-Frej M; Uronen-Hansson H; Gustafsson T; Mowat AM; Yrlid U; Lambrecht BN; Agace WW
Mucosal Immunol; 2012 Mar; 5(2):150-60. PubMed ID: 22166938
[TBL] [Abstract][Full Text] [Related]
10. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
[TBL] [Abstract][Full Text] [Related]
11. AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis.
Chai D; Yue Y; Xu W; Dong C; Xiong S
Antiviral Res; 2015 Jul; 119():68-77. PubMed ID: 25956163
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors.
Ding J; Zheng Y; Zhu F; Wang M; Fang L; Li H; Tian H; Liu Y; Wang G; Zheng J; Chai D
Int Immunopharmacol; 2023 Oct; 123():110722. PubMed ID: 37573687
[TBL] [Abstract][Full Text] [Related]
13. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional and Functional Analysis of CD1c
Bourdely P; Anselmi G; Vaivode K; Ramos RN; Missolo-Koussou Y; Hidalgo S; Tosselo J; Nuñez N; Richer W; Vincent-Salomon A; Saxena A; Wood K; Lladser A; Piaggio E; Helft J; Guermonprez P
Immunity; 2020 Aug; 53(2):335-352.e8. PubMed ID: 32610077
[TBL] [Abstract][Full Text] [Related]
15. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
Front Immunol; 2018; 9():2775. PubMed ID: 30542351
[TBL] [Abstract][Full Text] [Related]
16. Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.
Krueger PD; Kim TS; Sung SS; Braciale TJ; Hahn YS
J Immunol; 2015 Apr; 194(7):3213-22. PubMed ID: 25712214
[TBL] [Abstract][Full Text] [Related]
17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
18. Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection.
Beauchamp NM; Busick RY; Alexander-Miller MA
J Virol; 2010 Oct; 84(19):10191-9. PubMed ID: 20660207
[TBL] [Abstract][Full Text] [Related]
19. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
20. An enhanced immune response against G250, induced by a heterologous DNA prime‑protein boost vaccination, using polyethyleneimine as a DNA vaccine adjuvant.
Sun Z; Liu B; Ruan X; Liu Q
Mol Med Rep; 2014 Nov; 10(5):2657-62. PubMed ID: 25190325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
